Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Cash from Operations (2023 - 2025)

Rallybio (RLYB) has disclosed Cash from Operations for 3 consecutive years, with 4679000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 52.56% to 4679000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 29813000.0 through Dec 2025, up 39.51% year-over-year, with the annual reading at 29813000.0 for FY2025, 39.51% up from the prior year.
  • Cash from Operations hit 4679000.0 in Q4 2025 for Rallybio, up from 6550000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 4679000.0 in Q4 2025 to a low of 18765000.0 in Q1 2023.
  • Historically, Cash from Operations has averaged 11613333.33 across 3 years, with a median of 11031500.0 in 2023.
  • Biggest five-year swings in Cash from Operations: increased 15.31% in 2024 and later surged 52.56% in 2025.
  • Year by year, Cash from Operations stood at 11645000.0 in 2023, then grew by 15.31% to 9862000.0 in 2024, then skyrocketed by 52.56% to 4679000.0 in 2025.
  • Business Quant data shows Cash from Operations for RLYB at 4679000.0 in Q4 2025, 6550000.0 in Q3 2025, and 8379000.0 in Q2 2025.